As of 4:00pm ET
| +0.27 / +3.71%|
The 5 analysts offering 12-month price forecasts for Raptor Pharmaceutical Corp have a median target of 8.00, with a high estimate of 11.00 and a low estimate of 4.00. The median estimate represents a +6.10% increase from the last price of 7.54.
The current consensus among 5 polled investment analysts is to Buy stock in Raptor Pharmaceutical Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.